Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
Main Authors: | Chloe C. Fong, Julian Spencer, Quentin Howlett-Prieto, Xuan Feng, Anthony T. Reder |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1245622/full |
Similar Items
-
Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles
by: Chloe C. Fong, et al.
Published: (2023-04-01) -
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
by: Stefan Gingele, et al.
Published: (2018-12-01) -
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
by: Jérôme de Sèze, et al.
Published: (2023-03-01) -
NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy
by: Simone Dal Bello, et al.
Published: (2024-01-01) -
Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
by: Annika Klumpp, MD, et al.
Published: (2022-10-01)